Search Within

Leonard B Saltz

  1. "Advanced Practice Providers"
Formats
  1. Meeting Abstract (20)
  2. Journal Article (13)
Groups
  1. Advanced Practice Providers (33)
  2. Department of Medicine (33)
  3. Gastrointestinal Oncology Service (33)
  4. Solid Tumor Oncology Division (33)
  5. Nursing (32)
  6. Center for Pancreatic Cancer Research (23)

More Groups

People
  1. Ellen Hollywood (27)
  2. Diane Reidy (11)
  3. Marinela Capanu (10)
  4. Eileen O'Reilly (6)
  5. Nancy Kemeny (6)
  6. Andrea Cercek Hanjis (5)

More People

Years
  1. 2023 (1)
  2. 2022 (2)
  3. 2021 (1)
  4. 2020 (1)
  5. 2017 (2)
  6. 2016 (1)

More Years

Publications
  1. Journal of Clinical Oncology (20)
  2. Clinical Cancer Research (2)
  3. Pancreas (2)
  4. Annals of Oncology (1)
  5. Anticancer Research (1)
  6. Cancer (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (21)
  2. American Association for Cancer Research (2)
  3. Lippincott Williams & Wilkins (2)
  4. Oxford University Press (2)
  5. Elsevier Inc. (1)
  6. International Institute of Anticancer Research (1)

More Publishers

Results (33)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Colorectal cohort analysis from the intraperitoneal chemotherapy after cytoreductive surgery for peritoneal metastasis (ICARuS) clinical trial
    Meeting Abstract

    Nash, G. M.; Garcia-Aguilar, J.; Paty, P.; Gonen, M.; Foote, M. B.; Chung, S.; Mohamed, M.; Aguirre, N.; Weiser, M. R.; Rassam, R.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Randomized blinded study comparing injection site pain from octreotide long-acting-release (LAR) versus lanreotide during the treatment of well- differentiated neuroendocrine tumors (WDNETs)
    Meeting Abstract

    Raj, N.; Cruz, E.; Chou, J.; Capanu, M.; DeMore, A.; Hauser, H.; Heffernan, O.; Le, T.; Saltz, L.; Reidy-Lagunes, D.
    Pancreas (2022)

    Fulltext@MSK | Save
  • A randomized trial evaluating patient experience and preference between octreotide long-acting release and lanreotide for treatment of well-differentiated neuroendocrine tumors
    Journal Article

    Raj, N.; Cruz, E.; O'Shaughnessy, S.; Calderon, C.; Chou, J. F.; Capanu, M.; Heffernan, O.; DeMore, A.; Punn, S.; Le, T.; more...
    JCO Oncology Practice (2022)

    Fulltext@MSK | Save
  • Randomized blinded study comparing injection site pain from octreotide long-acting-release (LAR) versus lanreotide during the treatment of well differentiated neuroendocrine tumors (WDNETs)
    Meeting Abstract

    Raj, N. P.; Cruz, E.; Chou, J. F.; Capanu, M.; Heffernan, O.; Le, T.; Hauser, H.; Saltz, L. B.; Reidy, D. L.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Outcomes of ICU admission of patients with progressive metastatic gastrointestinal cancer
    Journal Article

    Epstein, A. S.; Yang, A.; Colbert, L. E.; Voigt, L. P.; Meadows, J.; Goldberg, J. I.; Saltz, L. B.
    Journal of Intensive Care Medicine (2020)

    Fulltext@MSK | Save
  • A phase I/II trial of MEK162 in combination with gemcitabine (G) and cisplatin (C) for patients (pts) with untreated advanced biliary cancer (ABC)
    Meeting Abstract

    Lowery, M. A.; O'Reilly, E. M.; Harding, J. J.; Yu, K. H.; Cercek, A.; Hollywood, E.; Salehi, E.; Margona, E.; Bradley, M.; Witter, T.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Phase II study of first-line trebananib plus sorafenib in patients with advanced hepatocellular carcinoma
    Journal Article

    Abou-Alfa, G. K.; Blanc, J. F.; Miles, S.; Ganten, T.; Trojan, J.; Cebon, J.; Liem, A. K.; Lipton, L.; Gupta, C.; Wu, B.; more...
    The Oncologist (2017)

    Fulltext@MSK | Save
  • Outcomes of ICU admission of patients with progressive metastatic gastrointestinal (GI) cancer
    Meeting Abstract

    Epstein, A. S.; Yang, A.; Colbert, L.; Voigt, L.; Meadows, J.; Goldberg, J.; Saltz, L.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • A phase I trial of binimetinib in combination with gemcitabine (G) and cisplatin (C) patients (pts) with untreated advanced biliary cancer (ABC)
    Meeting Abstract

    Lowery, M. A.; O'Reilly, E. M.; Harding, J. J.; Salehi, E.; Hollywood, E.; Bradley, M.; Sophos, N. A.; Ly, M.; Capanu, M.; Gerst, S. R.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • First stage results of a phase II trial of sorafenib plus doxorubicin (SD) in patients (pts) with advanced hepatocellular carcinoma (HCC) who progressed (POD) on sorafenib (S)
    Meeting Abstract

    Abou-Alfa, G. K.; Capanu, M.; Do, R. K. G.; Hollywood, E.; Ly, M.; Chou, J. F.; Lee, J. K.; Connell, L. C.; Wan, P. J.; Bradley, M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save